Alessio Paffoni

[Paola Vigano' @PaolaVigano3]

Grateful to work with an awesome team everyday @alepaffo @NoemiSalme30386 #paolovercellini #dadosomigliana #amerigovitagliano #giorgiadistefano

[Paola Vigano' @PaolaVigano3]

Findings important for women with #endometriosis 👁 @alepaffo @MairaCasalechi @JAMANetworkOpen

[Alessio Paffoni @alepaffo]

@PaolaVigano3 @MairaCasalechi Thank you
@PaolaVigano3
for your inspiring enthusiasm, and to all co-authors for this interesting result on #endometriosis 💖

[Paola Vigano' @PaolaVigano3]

New study on donor IVF cycles: Combining data from studies and registries (7212 + 162,082 cycles), findings show a very modest (~3%) reduction in live birth rates for recipients with endometriosis. @mairacasalechi @alepaffo https://t.co/zT1TZL3YGW

[Alessio Paffoni @alepaffo]

@SofiaMakieva @LabBoke @RitaVassena @FertStert @PaolaVigano3 Thank you for your thoughts @SofiaMakieva ! This is a very important point to clarify along with the possible presence of oocyte factors other than ploidy..

[Alessio Paffoni @alepaffo]

It was an eye-opening experience to attend this meeting with @alteri_ale as a teacher on errors and communication in ART. Thank you so much!

[Martina Balli @BalliMartina]

A big thank you to all the co-authors: Anna Cecchele, @PisaturoValerio, @SofiaMakieva, Giorgia Carullo, Edgardo Somigliana, @alepaffo and @PaolaVigano3

[Paola Vigano' @PaolaVigano3]

What was the statistical approach of WHO to estimate reference intervals for semen analysis? We have tried to assess this approach based on the recommendations of the International Federation of Clinical Chemistry https://t.co/pXJmzFL617

[Paola Vigano' @PaolaVigano3]

Thanks to @MinisteroSalute for the support to our SUNDRO study on vitamin D and infertility. All the results have been published:
https://t.co/1QkHl4JFW3
https://t.co/ESq3l6xVZg
https://t.co/2vFDY4f3NW
https://t.co/RMhWpbdfsK
#VitaminD #IVF @alepaffo @SofiaMakieva @GCermisoni

[Paola Vigano' @PaolaVigano3]

There is still a lot to understand on #ICSI outcomes. The issue on ICSI advantages and disadvantages will accept manuscripts until October 2022.
@alepaffo

[Alessio Paffoni @alepaffo]

@PisaturoValerio @rbejournal @PaolaVigano3 Nothing to add, just a little bit sad because nobody is considering your tweet. 😜

[Paola Vigano' @PaolaVigano3]

Proud to publish our re-evaluation of rescue ICSI in @rbejournal.@PisaturoValerio @alepaffo
https://t.co/rSOURzphyZ

[Alessio Paffoni @alepaffo]

Let’s say 95.990.400 USD #4 @muratpak

[Pak @muratpak]

@Sothebys @niftygateway 4/4: Equilibrium
#4 "The Oracle"
Quote tweet only. Guess. Only once.

[Alessio Paffoni @alepaffo]

@RitaVassena @LaStatale @AlbertoMLuciano @redbiolab @Valentina_Lodde Thank you Rita! The years seem to have passed only for me!!!

[Alessio Paffoni @alepaffo]

@RitaVassena @ESHRE :/ Here is what I was able to watch today starting at 9 am!

[Filomena Gallo @Filomena_Gallo]

Un grazie a Valeria Palermi che dirige @DRepubblicait. Qui trovate il suo editoriale: https://t.co/283lbIZm9b

[Alessio Paffoni @alepaffo]

@EllenFormi Forse il boom sonico di due aerei militari in transito...

[Alessio Paffoni @alepaffo]

@SofiaMakieva @MSCActions I’d like to congratulate you and the whole staff for this extraordinary achievement!

[Sofia Makieva @MakievaSofia]

Buon Natale a Milano! Merry Science to y’all 🔬🎄🎅🏽 https://t.co/awt2N35buu

[Alessio Paffoni @alepaffo]

@SofiaMakieva @theESHRE5 @ESHRE Need for revision of Alpha ESHRE consensus. Legal consequences are not negligible.